Vikram Solar IPO: A Comprehensive Guide for Indian Investors
Vikram Solar Ltd. is set to launch its initial public offering to raise Rs 2,080 crore. Here’s all you need to know about the IPO, including price band, GMP, financials, and more.
Vikram Solar Ltd. is set to launch its initial public offering to raise Rs 2,080 crore. Here’s all you need to know about the IPO, including price band, GMP, financials, and more.
The week ahead promises to be action-packed for financial markets, with Jerome Powell’s speech, key global economic data, and IPO buzz set to drive market trends. Get the latest updates and analysis.
This week brings a busy slate of corporate actions, with record dates lined up for several companies that have declared interim and final dividends. Here’s a list of key companies to watch, including Apollo Hospitals, HAL, RVNL, IRCTC, and more.
The benchmark equity indices closed flat on Wednesday, with shares of Wipro, Eternal, and HDFC Life contributing positively to the index. Nifty snapped its six-week losing streak, led by Apollo Hospital, Eternal, and Cipla.
Hindustan Copper’s Q1 profit takes a hit, down 29% to Rs 134 crore. What led to this decline and how will it impact investors? Get the latest updates on the Indian stock market and Q1 earnings.
Gulf Oil Lubricants reports 10% growth in standalone profit after tax to Rs 96.66 crore during the June quarter, driven by strong strategic execution and double-digit topline growth.
ReNew Power posts a multifold growth in net profit to Rs 513.1 crore for the June quarter, driven mainly by higher revenues from power sales. Get the latest updates on the Indian stock markets and Q1 results.
Inox Wind’s Q1 results are out, with net profit more than doubling to Rs 97.34 crore. What does this mean for investors and the future of renewable energy in India?
Patanjali Foods Ltd. reported a 31% decline in its year-on-year net profit for the first quarter of FY26, despite a 24% increase in revenue. Get the latest updates on the Indian stock markets and Q1 results.
Glenmark Pharmaceuticals’ Q1 results reveal an 86% drop in net profit despite a one-time gain. What does this mean for investors and the future of the company?